Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04725331
Title A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Transgene
Indications

Merkel cell carcinoma

lung non-small cell carcinoma

triple-receptor negative breast cancer

melanoma

sarcoma

Advanced Solid Tumor

non-Hodgkin lymphoma

Therapies

BT-001

BT-001 + Pembrolizumab

Age Groups: senior | adult
Covered Countries


No variant requirements are available.